Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04091165|
Recruitment Status : Recruiting
First Posted : September 16, 2019
Last Update Posted : September 16, 2019
|Condition or disease||Intervention/treatment|
|GI Cancer Nutritional Deficiency||Other: My Plate Calorie Tracker|
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery|
|Actual Study Start Date :||September 11, 2019|
|Estimated Primary Completion Date :||September 11, 2021|
|Estimated Study Completion Date :||September 11, 2022|
Participants will be identified for inclusion by leaders of the GI Clinic after GI surgery has been scheduled. Upon consenting, participants will be instructed how to download and use the mobile phone application "My Plate Calorie Counter".
Other: My Plate Calorie Tracker
My Plate Calorie Tracker is a user-friendly weight management, calorie record application, available for smart phone devices. Users have the option to input items manually (i.e., calories, carbohydrates, fats, and proteins), select from a list of popular food items, or scan barcodes on the food packaging. In addition to food entries, users can also enter daily water intake and physical activities. Once an account is created, data entered into the mobile application can be sync'd to the "My Plate Calorie Tracker" website.
Other Name: mobile application
- Usability of Smart Phone Application [ Time Frame: Up to 3 months ]Usability of smart phone application will be captured by (1) number of days that entries have been made by the study participants and recorded as a percentage of the total number of days after discharge from the hospital (obtained from mobile application (2) number of meals recorded in the application per day (obtained from mobile application) and (3) Exit Questionnaire (6 questions of 12). The Exit Questionnaire includes a mixture of 5-point Likert-scale, yes or no, and open-ended items to assess usability. Questions on the 5 point scale use 1 as an indication of difficulty in using application and 5 would be ease of use.
- Acceptability of Smart Phone Application [ Time Frame: Up to 3 months ]Patient's acceptability of the mobile application to assist with postoperative nutrition goals will be captured by the Exit Questionnaire (6 questions of 12). The Exit Questionnaire includes a mixture of 5-point Likert-scale, yes or no, and open-ended items to assess acceptability. Questions on the 5 point scale use 1 as an indication of acceptability issues of the application and 5 would be acceptability.
- Adherence to Recommended Nutritional Plan [ Time Frame: Up to 3 months ]Adherence to the participant's recommended nutritional plan will be calculated by participant's energy (caloric) intake over time, as recorded in the digital food diary, and compared to estimates of the optimum energy needs established by the dietician. Adherence will be reported as a percentage of estimated energy requirements.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04091165
|United States, Florida|
|H Lee Moffitt Cancer & Research Institute||Recruiting|
|Tampa, Florida, United States, 33612|
|Contact: Pamela J Hodul, MD 813-745-8459 Pamela.Hodul@moffitt.org|
|Principal Investigator: Pamela Hodul, MD|
|Sub-Investigator: Diana Castillo-Lopez|
|Sub-Investigator: Jason Fleming, MD, FACS|
|Sub-Investigator: Erin Gurd, RD,CSO, LD/N|
|Sub-Investigator: Kristen Lange, RD, CSO, LD/N|
|Principal Investigator:||Pamela Hodul, MD||H. Lee Moffitt Cancer Center and Research Institute|